Advertisement

Topics

The Actavis Group Company Profile

13:26 EST 13th December 2018 | BioPortfolio

Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries. Founded in 1956, the Group now operates across five continents and has its headquarters in Iceland. Today the Company has modern development and manufacturing facilities in Europe, the US and Asia. The plants produce a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi solids

Location

Dalshrauni 1, 220
Hafnarfirdi
Iceland

Contact

Phone: 354 535-2300
Fax: 354 535-2301
Email: actavis@actavis.com


News Articles [685 Associated News Articles listed on BioPortfolio]

English Court gives green light to Actavis for generic version of Alimta® in UK, France, Spain and Italy on basis of reconstitution in dextrose

Précis In a recent decision (Actavis & ors v Eli Lilly [2016] EWHC 234 (Pat)), the English High Court has granted declarations of non-infringement to Actavis, which was “clearing the ...

Amneal, Actavis settle generic Rytary litigation

Liabilities Update: AbbVie Wins AndroGel Re-Trial; Actavis To Settle Out Of Testosterone MDL

For second time, judge finds problem with jury verdict against AbbVie; Bayer withdraws its appeal of Xarelto pre-trial rulings pending...  

WHO Kick-Starts Pilot For Prequalification Of Biologics/Biosimilars

Manufacturers are being invited to submit expressions of interest in relation to two anticancer monoclonal antibodies on the WHO's essential...   

Actavis plc. rebrands on US Stock Exchange to Allergan plc.

Normal 0 false false false EN-GB X-NONE X-NONE Earlier this month, Actavis plc. announced that the company had adopted Allergan plc (NYSE: AGN) as its new global name.&nbs...

EMA's Modeling & Simulation Group Gears Up For Bigger Role With New Status

Modeling and simulation approaches are expected to play even a greater role in regulatory decision-making by the European Medicines Agency...    

Human medicines European public assessment report (EPAR): Telmisartan Actavis, telmisartan, Revision: 9, Authorised

BIA gets green light to intervene in Actavis/ICOS patent case

The Supreme Court has given its consent to the UK’s BioIndustry Association (BIA) to intervene in a case that the latter says “could have far-reaching impacts on the life sciences sector&r...

PubMed Articles [1737 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4126 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions

The purpose of this study is to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck & Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1...

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

A randomized, multicenter, double masked, placebo controlled, parallel group, bioequivalence study to evaluate the clinical equivalence and safety of Nepafenac 0.3% ophthalmic suspension (...

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

The purpose of this study to assess the single-dose relative bioavailability of Actavis Group hf and Pfizer (Norvasc®) 10 mg amlodipine besylate tablets, under fasting conditions.

A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions

The purpose of this study to assess the single-dose relative bioavailability of Actavis Group hf 50 mg venlafaxine hydrochloride tablets with Wyeth Pharmaceuticals (Effexor®) 50 mg venlaf...

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC h...

Companies [1645 Associated Companies listed on BioPortfolio]

Actavis Inc.

Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has ...

Actavis Group

Actavis is a fast growing company, headquartered in Iceland with modern development and manufacturing facilities in Europe, the U.S. and Asia and an extensive sales and marketing network in five conti...

The Actavis Group

Actavis' recent acquisition of the generics business of Alpharma positions the company among the five leading generic pharmaceutical companies in the world, with 10,000 employees in over 30 countries....

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

TransCelerate BioPharma Inc.

TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by accelerating and enhancing the research and development (...

More Information about "The Actavis Group" on BioPortfolio

We have published hundreds of The Actavis Group news stories on BioPortfolio along with dozens of The Actavis Group Clinical Trials and PubMed Articles about The Actavis Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Actavis Group Companies in our database. You can also find out about relevant The Actavis Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record